Motor learning of protective responses to balance perturbations in persons with Parkinson's Disease
帕金森病患者平衡扰动保护性反应的运动学习
基本信息
- 批准号:10574010
- 负责人:
- 金额:$ 4.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AgeAgonistAnteriorBalance trainingCharacteristicsClinical TrialsDevelopmentDoctor of PhilosophyElderlyEquilibriumFatal injuryFutureIndividualInterventionLearningMeasuresMethodsMotorMotor SkillsMuscleMusculoskeletal EquilibriumParkinson DiseaseParkinsonian DisordersPatientsPerformancePersonsPopulationPostural responsePostureProcessProtocols documentationPublic HealthRecurrenceRehabilitation therapyResearchScheduleSymptomsTestingTouch sensationTrainingWalkingantagonistfall injuryfall riskfallsflexibilityfollow-uphabituationimprovedlearning strategymotor learningpharmacologicresponseskill acquisitiontreadmill
项目摘要
Project Summary
Two-thirds of persons with Parkinson’s disease (PwPD) fall yearly, resulting in non-fatal and fatal injuries. Many
of these patients are recurrent fallers, due primarily to parkinsonian symptoms that interfere with postural control
and limit postural responses to both self-initiated and external perturbations. These symptoms cause excessive
co-contraction of agonists and antagonist muscle groups, hypometria, delayed stepping, and postural set
inflexibility (i.e., an inability to quickly change responses to different types, conditions, and intensities of postural
disturbances). Even with pharmacological and rehabilitation interventions, postural and balance deficits persist,
and the risk of falls remains intractable. Among older adults, balance perturbation training is emerging as an
effective method to reduce fall related injuries. In PwPD, however, one of the challenges to balance training is
that postural inflexibility may negatively impact motor skill acquisition, retention, and generalization. As a result,
motor learning strategies that are effective in individuals without PD may not be effective in PwPD. The overall
objective of this PhD dissertation proposal is to determine the effect of practice schedule on the acquisition,
retention, and generalization of protective balance responses in PwPD. The central hypothesis is that PwPD will
acquire and retain protective balance responses to treadmill perturbations through blocked, but not random,
initial practice schedules, and will require a follow-up set of random practice to generalize improvements to
overground perturbations. In specific aim 1, I will compare improvements in protective stepping stability after a
single session of blocked versus random practice of 10 slips and 10 trips in PwPD and age-matched healthy
controls. In specific aim 2, I will compare generalization of protective stepping stability to unpracticed overground
slip perturbations after blocked, followed by random practice sessions (blocked-random) to random, followed by
blocked (random-blocked) practice sessions of treadmill-induced perturbations (10 slips and 10 trips) in PwPD
and controls. Together, these findings will provide a basis for developing balance rehabilitation protocols based
on motor learning principles to mitigate falls in PwPD compared to age-matched controls.
项目摘要
三分之二的帕金森病(PwPD)患者每年都会摔倒,导致非致命性和致命性伤害。许多
这些患者的复发性跌倒,主要是由于帕金森症状干扰姿势控制
并限制对自我引发和外部扰动的姿势反应。这些症状会导致过度
激动肌群和拮抗肌群的共同收缩、测量不足、延迟踏步和姿势固定
可识别性(即,无法快速改变对不同类型、条件和强度的姿势的反应
干扰)。即使有药物和康复干预,姿势和平衡缺陷仍然存在,
并且福尔斯的风险仍然难以处理。在老年人中,平衡扰动训练正在成为一种
减少跌倒相关伤害的有效方法然而,在PwPD,平衡训练的挑战之一是
姿势不稳定性可能对运动技能的获得、保持和概括产生负面影响。因此,在本发明中,
在没有PD的个体中有效的运动学习策略在PwPD中可能无效。整体
这篇博士论文的目的是确定实践时间表对获取的影响,
保留和PwPD中保护性平衡反应的泛化。核心假设是,PwPD将
获得并保持对跑步机扰动的保护性平衡反应,通过阻断,但不是随机的,
最初的实践时间表,并将需要一个后续的随机实践,以推广改进,
地面扰动在具体目标1中,我将比较在保护性步进稳定性方面的改进,
在PwPD和年龄匹配的健康人中进行10次滑倒和10次绊倒的单次封闭与随机练习
对照在具体目标2中,我将比较保护性踏步稳定性的一般化与未练习过的地上
滑动扰动后,封锁,其次是随机练习会议(封锁随机),以随机,其次是
在PwPD中,对由球磨机引起的扰动进行封闭(随机封闭)练习(10次失误和10次跳闸)
和控制。总之,这些研究结果将为制定基于平衡的康复方案提供基础。
运动学习原则,以减轻福尔斯下降PwPD相比,年龄匹配的控制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruth Yetunde Akinlosotu其他文献
Ruth Yetunde Akinlosotu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 4.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 4.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别: